http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20927748

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase I|Clinical Trial, Phase II|Journal Article|Randomized Controlled Trial
endingPage 4628
issn 0264-410X
issueIdentifier 35 Pt B
pageRange 4621-4628
publicationName Vaccine
startingPage 4621
bibliographicCitation Madan A, Collins H, Sheldon E, Frenette L, Chu L, Friel D, Drame M, Vaughn DW, Innis BL, Schuind A. Evaluation of a primary course of H9N2 vaccine with or without AS03 adjuvant in adults: A phase I/II randomized trial. Vaccine. 2017 Aug 16;35(35 Pt B):4621–8. doi: 10.1016/j.vaccine.2017.07.013. PMID: 28720281.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f26e398f5775a396d1b92f627d37655d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_259d43f7a99abb7540da2a637f7628ad
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc311077de7d0cde3b7ec08b4e933a91
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7cb2cf571eb0c81a8a23252aa1d9f0f4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8212-3607
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c7a13c14f239cb347d0c09b49862360
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21fc86dff5026559764f6408fa3b52f2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_08b15f05468d59ea6210e0e4c10b7ccb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9fdd6686ddee26716db54681731e8778
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e155c4b7775f598cd396bbf8901a230
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8d3824c6efa114a810ba869c2918a1af
date 2017-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1016/j.vaccine.2017.07.013
https://pubmed.ncbi.nlm.nih.gov/28720281
isPartOf https://portal.issn.org/resource/ISSN/0264-410X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/7945
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Evaluation of a primary course of H9N2 vaccine with or without AS03 adjuvant in adults: A phase I/II randomized trial
discusses http://id.nlm.nih.gov/mesh/M0020400
http://id.nlm.nih.gov/mesh/M0370590
http://id.nlm.nih.gov/mesh/M0006823
http://id.nlm.nih.gov/mesh/M0000431
http://id.nlm.nih.gov/mesh/M0011310
http://id.nlm.nih.gov/mesh/M000751244
http://id.nlm.nih.gov/mesh/M0001361
http://id.nlm.nih.gov/mesh/M0017253
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000071497
http://id.nlm.nih.gov/mesh/D024502Q000276
http://id.nlm.nih.gov/mesh/D000276Q000009
http://id.nlm.nih.gov/mesh/D013185Q000276
http://id.nlm.nih.gov/mesh/D007252Q000276
http://id.nlm.nih.gov/mesh/D053127Q000276
hasSubjectTerm http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D006385
http://id.nlm.nih.gov/mesh/D009500
http://id.nlm.nih.gov/mesh/D011136Q000009
http://id.nlm.nih.gov/mesh/D000914Q000097
http://id.nlm.nih.gov/mesh/D055815
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D024502Q000009
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D007252Q000009
http://id.nlm.nih.gov/mesh/D007252Q000008
http://id.nlm.nih.gov/mesh/D004338
http://id.nlm.nih.gov/mesh/D007251Q000517
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D013185Q000009
http://id.nlm.nih.gov/mesh/D007156
http://id.nlm.nih.gov/mesh/D014611Q000379
http://id.nlm.nih.gov/mesh/D058873Q000517
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID638072
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7774

Total number of triples: 67.